5 Yasmin/Yaz Blood Clot Victims File Lawsuit Against Bayer
By Christina Drury
Bayer has had yet another lawsuit filed against them and their birth control medications Yaz or Yasmin. This new Yaz/Yasmin lawsuit adds to the growing multidistrict litigation (MDL) that is located in the U.S. District Court for the Southern District of Illinois. The new Yaz lawsuit was filed on behalf of several plaintiffs who allege they have each suffered from serious side effects caused by Yasmin and Yaz. Some of the side effects the plaintiffs suffered include gallbladder problems, pulmonary embolism, stroke, heart attack and blood clots. The Yasmin lawsuits list strict liability and negligence as the causes of action, stating that Bayer had knowledge or should have known about the risks entailed with the use of Yaz and Yasmin and failed to warn doctors and patients of the potential dangers of the medications.
Multiple Medical Complications Listed in Yaz/Yasmin Lawsuit
The five plaintiffs represented in the Yasmin/Yaz lawsuit allege they suffered medical complications as a direct result of using the drugs. The plaintiffs and their Yasmin/Yaz side effects are as follows:
- Eyvette Johnson developed Yasmin blood clots after using the drug for over a year.
- Stephanie Lyons suffered a Yaz stroke and died after using the drug for a little over a month. (Her estate is suing Bayer.)
- Anita Luckenbaugh was diagnosed with Yasmin Pulmonary Embolism and Deep Vein Thrombosis after taking the drug for over a year.
- Kayla Ann Mies developed severe gallbladder complications after taking the drug for six years. The complications led to the eventual removal of her gallbladder.
- Glenda Thomas suffered a heart blockage after taking Yaz for four months
Each plaintiff claims that they would not have chosen to take the birth control medications had they known what the risks were and the complications they would suffer. The Plaintiffs are seeking compensation for mental anguish, all medical costs, diminished quality of life and pain and suffering.
Warning Letter Issued by FDA
Bayer marketed Yaz and Yasmin as a better form of birth control that could prevent pregnancy, treat premenstrual syndrome and reduce acne. The FDA issued a warning letter based on clinical studies that contradicted the claims made by Bayer that Yaz and Yasmin were safer or more effective than other forms of birth control. These same studies also revealed the associated dangers of Yaz and Yasmin including an increased risk of heart attack, deep vein thrombosis and other complications. The FDA chose not to approve of Bayer marketing the medication for any other purpose other than birth control.
Yasmin/Yaz Lawsuit Accuses Bayer of Withholding Knowledge of Risks
The plaintiffs allege in the Yaz/Yasmin lawsuit that Bayer had access to and knowingly withheld studies that revealed that women who took the drug had an increased risk of suffering from Pulmonary Embolism and Deep Vein Thrombosis. If you have taken or know someone who has taken Yaz or Yasmin and has suffered any complications or injuries as a result, you may be entitled to compensation. Visit our Yaz/Yasmin, Beyaz & Ocella Birth Control Pill Class Action Lawsuit Settlement & Investigation page for more information about the birth control drug and the lawsuits that have been filed against Bayer.
Updated January 7th, 2013
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement